Interpace Biosciences IDXG
OTC IDXG
$5.40 +0.15 (+2.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Interpace Biosciences (IDXG) EBITDA Margin (2010 - 2026)

Updated

Interpace Biosciences (IDXG) posted EBITDA Margin of 4.91% for Q2 2026, up 8.88 percentage points from -3.98% a year earlier but down 8.83 percentage points from the prior quarter.

Analysis

Interpace Biosciences (IDXG) EBITDA Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Interpace Biosciences was 12.84%, down 0.58 percentage points year-over-year; for FY2025, it was 11.64%, down 6.27 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of +75.12 percentage points (FY2020 to FY2025).
  • In prior years, Interpace Biosciences' EBITDA Margin was 17.92% in FY2024 (+5.47 pp), 12.44% in FY2023 (+15.76 pp), -3.32% in FY2022 (-0.42 pp) and -2.90% in FY2021 (+60.57 pp).
  • Quarterly EBITDA Margin has run from a low of -15.20% in Q2 2022 to a high of 22.41% in Q2 2024 over five years.
  • On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of -0.63 percentage points.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2021, with a gain of 64.17 percentage points; the weakest was Q2 2025, with a drop of 26.39 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was 13.74% (Q1 2026), 18.38% (Q4 2025) and 14.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 HCA Healthcare 103.18 Bn 99.19 Bn - 20.01%
2 Natera 57.81 Bn 53.49 Bn 485.19 Mn -7.25%
3 Labcorp Holdings 26.94 Bn 24.69 Bn 1.11 Bn 16.90%
4 Quest Diagnostics 26.85 Bn 24.98 Bn 1.03 Bn 19.88%
5 Guardant Health 22.51 Bn 18.57 Bn 219.03 Mn -35.69%
6 Tenet Healthcare 22.37 Bn 11.37 Bn - 30.60%
7 Fresenius Medical Care AG 13.20 Bn 5.15 Bn 1.52 Bn 16.93%
8 BrightSpring Health Services 12.39 Bn 10.72 Bn 492.75 Mn 4.51%
9 Encompass Health 12.26 Bn 11.92 Bn - 24.09%
10 Interpace Biosciences 180.06 Mn 170.78 Mn 5.65 Mn 4.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.91%
Mar 31, 2026 13.74%
Dec 31, 2025 18.55%
Sep 30, 2025 14.53%
Jun 30, 2025 -3.81%
Mar 31, 2025 16.80%
Dec 31, 2024 17.37%
Sep 30, 2024 19.41%
Jun 30, 2024 22.41%
Mar 31, 2024 11.46%
Dec 31, 2023 15.42%
Sep 30, 2023 7.24%
Jun 30, 2023 14.38%
Mar 31, 2023 12.51%
Dec 31, 2022 5.08%
Sep 30, 2022 -1.60%
Jun 30, 2022 -14.92%
Mar 31, 2022 -2.35%
Dec 31, 2021 -3.47%
Sep 30, 2021 -4.91%
API Access

Interpace Biosciences EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IDXG&period=max&api_key=YOUR_API_KEY